Related Experiment Video
Updated: May 20, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Outcome of neonates exposed to active pulmonary tuberculosis
Suchaorn Saengnipanthkul1, Junya Jirapradittha, Pakaphan Kiatchoosakun
1Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Suchaorn@hotmail.com
Insights
Neonatal tuberculosis exposure requires isoniazid (INH) prophylaxis and monitoring. Six months of INH prophylaxis effectively prevented active tuberculosis in exposed infants during a 30-month follow-up.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Neonatal exposure to active pulmonary tuberculosis presents a significant risk for infection and disease.
- Early identification and intervention are crucial for preventing tuberculosis transmission in vulnerable newborns.
Purpose of the Study:
- To determine the incidence of tuberculosis infection and disease in neonates exposed to an active pulmonary tuberculosis patient.
- To evaluate the efficacy of isoniazid (INH) prophylaxis in preventing tuberculosis in this high-risk group.
Main Methods:
- A descriptive cohort study involving 48 neonates exposed to a smear-positive pulmonary tuberculosis mother.
- Administration of six months of isoniazid (INH) prophylaxis to exposed neonates.
- Follow-up included chest X-rays and tuberculin skin tests (TST) at 24 months and extended to 30-32 months.
Main Results:
- No neonates who received INH prophylaxis progressed to active tuberculosis.
- Tuberculin skin tests (TST) were negative in all 45 neonates tested.
- Transient abnormal chest X-rays (hilar lymphadenopathy, pneumonia) were observed in nine neonates but resolved.
Conclusions:
- Isoniazid (INH) prophylaxis, coupled with long-term follow-up, is effective in preventing active tuberculosis in neonates exposed to infectious pulmonary tuberculosis.
- This intervention is critical for high-risk neonatal populations to mitigate tuberculosis development.
Objective:
To determine the incidence of tuberculosis infection and disease in neonates exposed to an active pulmonary tuberculosis patient in a nursery and maternity ward.
Material And Method:
Descriptive cohort study was carried out in Srinagarind Hospital, Khon Kaen University, North-East Thailand. A smear positive pulmonary tuberculosis mother with productive cough was diagnosed on the fifth day of admission. The authors urged parents of all exposed neonates to accept isoniazid (INH) prophylaxis for their infants for six months. All neonates underwent chest x ray (AP, lateral view) and tuberculin skin test on the 24 months follow-up.
Results:
The 48 neonates were identified as exposed. The age of follow-up ranged from 30 to 32 months. Only three were lost to follow-up. Of the remaining 45 neonates, six refused to take INH prophylaxis. Complete six months of LNH prophylaxis were observed in 27 (60%) of 39 contacts. Tuberculin skin tests (TST) were performed in all of 45 contacts. No cases were positive for TST. Abnormal chest radiographies were found in nine of INH group, three patients had hilar lymphadenopathy and six had pneumonia. The repeat chest x ray, two weeks later was normal in all cases. After 30 to 32 months follow-up, none of the 39 neonates who received INH prophylaxis or the six neonates progressed to have active tuberculosis.
Conclusion:
In exposed neonate identified as the high-risk group, appropriate INH prophylaxis, and long-term follow-up, especially in the first-2 years, seemed to be effective in preventing the development of active tuberculosis.
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Cycle: Exhalation